Adjusting the timing or, where possible, the dose can sometimes help
Your medication will be shipped directly to you at your home, along with clear instructions for self-administration
A recent phase 2 trial investigated the triple biased GLP-1/GIP/GCC receptors agonist retatrutide (LY3437943) in 338 patients with a mean age of 48 years and BMI of 37.3 kg/m 2 without diabetes (prediabetes in 36% participants) showing BW and WC reduction ranging from 8.7% to 24.2% and 6.5 cm to 19.6 cm in the 1 mg and 12 mg dose groups, respectively, at 48 weeks 41
NICE, Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes [TA390]
Thus, the correlation between GLP-1RAs and tumors has also become a focus of attention in recent years
Some options include: Coconut water which contains potassium and other electrolytes but is low in sugar